Community lists
Samengesteld · Gezondheidszorg

Big pharma

Door InspectStocksPublished 14 okt 202613 companies0 followers

The largest drugmakers, selling prescription medicines worldwide.

Gegroepeerd met hulp van een AI-model en nagekeken door onze redactie. De regel onder elk bedrijf zegt waarom het hier staat.

Sign in to followSign in to copy
Download image
KaartenNiveaus
A
  • LLYELI Lilly
    US$ 1.437,79+42,2% 1Y

    Sells prescription medicines for diabetes, obesity, cancer and inflammation

  • JNJJohnson & Johnson
    US$ 280,34+47,5% 1Y

    Sells prescription medicines for cancer and immune disorders

  • MRKMerck
    US$ 147,20+65,7% 1Y

    Sells prescription medicines and vaccines for people and animals

  • NVSNovartis
    US$ 160,36+23,6% 1Y

    Sells prescription medicines

  • AMGNAmgen
    US$ 468,13+43,1% 1Y

    Develops and sells medicines and biosimilars for serious diseases

  • GSKGSK
    US$ 50,60+8,9% 1Y

    Sells prescription medicines and vaccines worldwide

  • TAKTakeda Pharmaceutical
    US$ 20,86+50,1% 1Y

    Sells prescription medicines and vaccines globally

B
  • ABBVAbbVie
    US$ 294,87+30,2% 1Y

    Sells medicines for immune, neurological and cancer conditions

  • AZNEén stap lager omdat de groei wegebtAstrazeneca
    US$ 185,49+115,2% 1Y

    Sells prescription medicines

  • SNYSanofi
    US$ 48,43-3,0% 1Y

    Sells prescription medicines and vaccines

C
  • NVONovo Nordisk A/S
    US$ 41,10-15,4% 1Y

    Sells diabetes and obesity medicines

  • PFEEén stap lager omdat de groei wegebtPfizer
    US$ 29,45+21,4% 1Y

    Sells prescription medicines and vaccines

  • BMYBristol-Myers Squibb
    US$ 62,92+34,0% 1Y

    Sells prescription medicines for cancer and immune conditions

D

Geen enkel bedrijf hier heeft dit cijfer.

F

Geen enkel bedrijf hier heeft dit cijfer.

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.